Table 3.
Outcome comparison among patients who received IV, IA, or combined IV + IA treatments
| N (%) by year | |||||||
|---|---|---|---|---|---|---|---|
| Variables | Year 2007 | Year 2008 | Year 2009 | Year 2010 | Year 2011 | Year 2012 | P value for trend |
| Symptomatic ICH | |||||||
| IV therapy | * | 60 (5.8) | 76 (5.1) | 85 (3.9) | 107 (4.4) | 107 (3.7) | .003 |
| IA therapy | * | 14 (7.9) | 21 (7.7) | 27 (7.4) | 20 (3.7) | 28 (4.3) | .003 |
| IV + IA therapy | * | 6 (12.8) | 3 (4.0) | 14(11.3) | 14 (8.9) | 16 (7.1) | NS |
| Life-threatening complication | |||||||
| IV therapy | * | 14 (1.4) | 12 (.8) | 19 (.9) | 18 (.7) | 22 (.8) | .13 |
| IA therapy | * | 3 (1.7) | 3(1.1) | 2 (.5) | 5 (.9) | 3 (.5) | NS |
| IV + IA therapy | * | 1 (2.1) | 3 (4.0) | 3 (2.4) | 2(1.3) | 0 | NS |
| In-hospital mortality | |||||||
| IV therapy | 55 (9.5) | 88 (8.6) | 133 (9.0) | 174 (8.0) | 169 (6.9) | 167 (5.7) | <.001 |
| IA therapy | 8 (21.1) | 33 (18.5) | 48 (17.6) | 62 (16.9) | 97 (18.0) | 95 (14.6) | NS |
| IV + IA therapy | 4 (40.0) | 6 (12.8) | 21 (28.0) | 21 (16.9) | 29 (18.4) | 24 (10.6) | NS |
| Ambulating at discharge | |||||||
| IV therapy | 177 (30.7) | 342 (33.3) | 529 (35.7) | 747 (34.6) | 902 (37.1) | 1182(40.4) | <.001 |
| IA therapy | 6 (15.8) | 38 (21.3) | 49 (18.0) | 59 (16.1) | 110(20.4) | 146 (22.5) | NS |
| IV + IA therapy | 3 (30.0) | 15 (31.9) | 11 (14.7) | 20(16.1) | 36 (22.8) | 63 (27.9) | NS |
| Discharge home | |||||||
| IV therapy | 175 (30.4) | 335 (32.6) | 534 (36.0) | 884 (40.9) | 930 (38.2) | 1091 (37.3) | .0005 |
| IA therapy | 7 (18.4) | 38 (21.3) | 52(19.1) | 71 (19.4) | 103 (19.1) | 127 (19.6) | NS |
| IV + IA therapy | 3 (30.0) | 12 (25.5) | 11 (14.7) | 19 (15.3) | 37 (23.4) | 52 (23.0) | NS |
Abbreviations: IA, intra-arterial; ICH, intracerebral hemorrhage; IV, intravenous; NS, not significant.
*
Data not available.